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The appearance of wheezes and changes in inspiratory breath (vesicular) sound intensity (BSI) were 
monitored in patients undergoing routine methacholine challenge test (MCT). The results were 
compared with changes in spirometry and to airway hyper-responsiveness (AH). 
Fifty-four patients were examined. Spirometry was performed before and after the inhalation of 
cumulative doses of methacholine starting from 25pg; a fall in forced expiratory volume in 1 s (FEV,) 
by 20% or more was considered as significant. Lung auscultation was performed by two observers 
simultaneously using a special stethoscope placed sequentially over the posterior right and left upper 
(interscapular region, 5 cm from the fourth thoracic vertebra) and lower lung zones (5 cm below the 
scapulae). Symptoms were recorded by the patients on a visual analogue scale. 
In 27 patients, the MCT was positive (MCT+) and in 27 patients it was negative (MCT - ). Wheezes 
were identified at PD,, in 12 MCT + patients while reduced BSI alone was found in 11 patients; in four 
patients, auscultation was normal. In 20 MCT+ patients, either wheezes, diminished BSI or both were 
heard, one to several steps before reaching PD,,. In the MCT - group, wheezes were detected in two 
patients and diminished BSI in four. In MCT+ patients, the mean ( f SD) perception of symptoms at 
end-challenge was 33% ( f 26), whereas in MCT - patients, it was 13.6% ( f 22). Complete inter- 
observer agreement was found in 95.7% of ausculations performed (Kappa coefficient=0.846). 
Coupled to spirometry, lung auscultation may prove useful in airway challenge testing provided the 
concept is accepted that wheeze appearance and, by extension, an acute decrease in BSI, is as legitimate 
a manifestation of AH as a fall in FEV,. 
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Introduction 
Respiratory wheezes are a common auscultatory 
finding in bronchial asthma; together with 
cough, chest tightness and dyspnoea, they are 
usually associated with airflow obstruction 
and airway hyper-responsiveness (AH). In the 
laboratory, AH can be demonstrated by inhaling 
increasing doses (or concentrations) of a neb- 
ulized mediator (e.g. methacholine) until a 20% 
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drop in forced expiratory volume in 1s (FEV,) 
occurs (1). 
Using a simple stethoscope, Avital et al. (2) 
first showed that wheeze detection over the 
trachea was useful to determine the degree of 
airway responsiveness in asthmatic children too 
young to perform spirometry. However, subse- 
quent studies showed that wheezes were only 
moderately-sensitive detectors of a 20% fall in 
FEV, in older children with suspected asthma 
alone (3), or in adults exposed to occupational 
hazards (4). 
As the accuracy of wheezes to quantify airflow 
obstruction seems far from established, the 
authors wondered whether lung auscultation 
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during bronchial provocation testing (BPT) was 
useful at all. To address this question, two 
studies were carried out independently by two 
teams of investigators. In the first, lung sounds 
were monitored using a computerized sound 
recording and analysing system (5). In the 
second, reported herein, lung sounds were 
monitored by two observers auscultating simul- 
taneously with a special stethoscope. This 
clinical experiment was important because 
standardization of equipment and protocols is 
lacking; therefore, the results of studies dealing 
with computerized sound analysis are not easy to 
generalize. 
Patients and Methods 
The study group was made up of 54 consecu- 
tive patients undergoing routine methacholine 
challenge test (MCT) at the Department of 
Chest Disease, Hopitaux Universitaires de 
Strasbourg between August 1993 and April 
1994. Their pre-study characteristics are shown 
in Table 1. Patients were asked to stop theophyl- 
line and anti-cholinergics for 48 h and p2 ago- 
nists for 12 h before the test, if they were using 
them. None of the patients were on inhaled 
corticosteroids. 
METHACHOLINE CHALLENGE 
Cumulative doses of a methacholine solution 
(10 mg ml - ‘) were inhaled as generated by a 
nebulizer (Mediprom Dosimeter FDC 88, 
Mediprom, 75014 Paris, France); a nose clip was 
worn and the aerosol was inhaled through the 
mouth by slow inspiratory capacity manoeuvres 
each separated by a 5-s breath hold. The nebul- 
ization system consisted of a compressor giving 
an air flow of 5-8 1 min - ‘, which was adjusted 
for different time durations in order to release 
25, 50 or 100 pug methacholine when passed 
through a De Vilbiss 5610 D nebulizer (De 
Vilbiss, Somerset, PA, U.S.A.). 
At baseline, the patient was asked to inhale 
one puff of diluent (normal saline), starting from 
functional residual capacity (FRC) to total lung 
capacity (TLC). This was followed by the in- 
halation of doubling doses of methacholine 
at 3-min intervals starting from 25pg up to 
3200 ,ug. 
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36.3 ( f 13.4) (range 6-59) 
169.8 (f 10.7) 








Chronic cough 7 
Dyspnoea on exertion 5 
Miscellaneous 10 
Baseline lung function Observed %Predicted 
FEV, 1 ( f SD) 3.33 ( f 0.91) 95.8 ( f 14.9) 
FVCl (&SD) 3.94 ( f 1.15) 97.2 ( II= 11.7) 
MEF,, - ’ ( f SD) 3.85 ( f 1.42) 83.2 ( zt 29.2) 
FEV,, forced expiratory volume in 1 s; FVC, forced 
vital capacity; MEF,,, maximum expiratory flow at 
50% of the vital capacity. 
Spirometry was done by an experienced nurse 
(J.L.) by having the patients expire maximally 
into an electronic spirometer (Autospiro 500, 
Minato Medical Science Co. Ltd., Osaka, 
Japan) after a maximal inspiratory manoeuvre. 
Maximal expiratory flow-volume (MEFV) and 
volume-time curves were obtained, the quality 
of which could be controlled by visually inspect- 
ing the screen of the spirometer; at least three 
forced expiratory manoeuvres were done at the 
baseline step of the test. Thereafter, the best of 
two curves was retained. The best expiratory 
manoeuvre was that showing the highest sum of 
FEV, + forced vital capacity (FVC). From the 
various indices calculated automatically, FVC 
and FEV, were retained for analysis. The test 
was terminated when either the PD,, was 
AIRWAYRESPONSWENESSANDABNORMALLUNGSOUNDS 153 
obtained, or when the maximum cumulative 
dose of methacholine was reached. Percent fall in 
FEV, was calculated by the formula: 
Baseline FEV, - Post-provocation FEV, x 1OO 
Baseline FEV, 
LUNG AUSCULTATION 
This was done independently by two experienced 
observers - a pulmonary physician (A.P.) and a 
nurse (L.M.) - neither of whom were aware of 
the results of spirometry. To made sure that 
disagreements did not occur because of improper 
use of lung sound terminology, the observers 
underwent a practice run before the study. 
Auscultation was performed before the begin- 
ning of the test and during the last minute or so 
of the time period after each aerosol inhalation. 
In order to avoid the influence on respiratory 
sounds of possible changes in bronchomotor 
tone due to the forced expiratory manoeuvres, 
breath sounds were assessed systematically 
before spirometry. The stethoscope used was 
made from two identical, commercially available 
stethoscopes, assembled in such a manner that 
the ear piece flexible tubing of each stethoscope 
was connected to a single stethoscopic head by 
means of a T-piece (Fig. 1). This assembly allows 
both observers to listen to the same sound at the 
same time. 
Patients were asked to make deep inspirations 
through the mouth as fast as possible starting 
from functional residual capacity followed by a 
passive expiration. Meanwhile, the stethoscope 
was placed over the following sites over the 
posterior chest wall in succession: right and left 
upper zones (interscapular region, 5 cm from the 
fourth thoracic vertebra) and right and left lower 
zones (5 cm below the scapulae). 
Two types of lung sounds were monitored 
throughout the challenge test; wheeze appear- 
ance and changes in inspiratory breath sound 
intensity (BSI). Wheezes were defined as musical, 
whistling sounds heard during either the inspira- 
tory or expiratory phases of the respiratory 
cycle, or both. Inspiratory BSI was recorded 
either as equal to, or diminished, as compared 
with baseline. Each observer recorded his/her 
findings separately on an appropriate form for 
later comparison. 
FIG. 1. Special stethoscope used for simultaneous 
ausculation. 
PERCEPTION OF SYMPTOMS 
To assess the relationship between acoustic find- 
ings and perception of symptoms, each patient 
was asked to record his or her symptoms (degree 
of breathlessness, cough, chest discomfort etc.) 
after each methacholine inhalation on a visual 
analogue scale (16 cm) ranging from 0% on the 
extreme right (no symptoms) to 100% on the 
extreme left (severely symptomatic). 
STATISTICAL ANALYSIS 
The sensitivity and specificity of abnormal lung 
sounds to detect airflow obstruction were calcu- 
lated by taking a 20% fall in FEV, as reference 
test according to standard formulae (6). 
Observer agreement was calculated by the kappa 
coefficient (7). Because both observers had a 
comparable experience on lung auscultation, 
there was no apriuri reason to take the results of 
auscultation performed by one of them as the 
gold standard. Thus, and also to minimize inter- 
observer disagreement, auscultation was consid- 
ered positive for a signal only when it was 
detected by both observers (4). 
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TABLE 2. Inter-observer agreement* in lung auscul- 
tation 
Observer LM 
NBS LBSI WH Total 
NBS 1622 20 10 1652 
Observer AP LBSI 24 174 19 217 
WH 7 4 80 91 
Total 1653 198 109 1960 
*Complete observer agreement = 1876 times (95.7%); 
Kappa coefficient k=0.846. NBS, normal breath 
sounds; BSI, breath sound intensity; WH, wheezes. 
Results 
MCT 
Of 54 patients, 27 (50%) had a positive MCT 
(MCT+) and 27 had a negative MCT (MCT - ). 
Among MCT+ patients, 17 had asthma due 
to allergy to different aeroallergens, eight had 
occupational asthma, one was investigated for 
chronic cough and one had allergy to latex. 
Among MCT - patients, 20 were non- 
asthmatics, two had allergic asthma and five had 
occupational asthma. Among the latter patients, 
one was suspected as being allergic to wheat 
flour, and the remaining patients were tested 
after long avoidance to isocyanates. 
Mean ( f SD) FEV, at baseline in MCT+ 
patients was 3.04 1 ( f 0*67), which fell to 2.25 1 
( f O-55) at the end of the test (PD&, with a 
mean ( f SD) percent drop in FEV, of 26.4% 
( f 6.5). In MCT - patients, the observed values 
were 3.61 1 ( f 1.03) at baseline and 3.42 1 
( f O-97) at the end of the test, with a mean 
( f SD) percent fall in FEV, of 5.5% ( f 4.2). 
OBSERVER AGREEMENT 
A total of 1952 auscultations were performed by 
each observer over the chest; out of 1960 breath 
sounds heard, complete observer agreement was 
found in 1876 instances, i.e. 95.7% (k=O*846) 
(Table 2). 
AUSCULTATION IN MCT+ PATIENTS (n=27) 
At PD,,, wheezes (associated or not with 
reduced inspiratory BSI) were found in 12 
patients while a diminished BSI alone was found 
in 11 patients; in the remaining four patients, 
auscultation was normal throughout the test. 
Incidentally, in 20 patients (74%), abnormal 
breath sounds (ABS) - that is either wheeze, 
diminished BSI or both -were heard one to six 
steps before PD,, was reached; six steps in one 
patient, five steps in two, three in one, two in six 
and one in ten. 
In 14 patients (51*8%), ABS were heard only 
in the lower lung zones, but none of the patients 
had ABS in the upper lung zones alone. 
AUSCULTATION IN MCT - PATIENTS (n=27) 
Abnormal lung sounds were heard in six (22%) 
patients with an MCT - ; wheezes were detected 
in two and a diminished BSI in four. One 
wheezing patient had severe symptoms but his 
FEV, fell by only 14*3%, so that the test was 
considered negative by spirometric criteria. 
Mean ( f SD) baseline FEV, in the above six 
patients was 4.24 1 ( f 1.20) and 3.92 1 ( f l-10) 
at the end of the test, with a mean fall in FEV, of 
7.1% ( f 6-O). 
PERCEPTION OF SYMPTOMS 
In 25 MCT+ patients, the mean ( f SD) percep- 
tion of symptoms at PD,, was 33 f 26% (range 
O-95%) on the visual analogue scale. The mean 
perception of symptoms in MCT - patients 
(n=22) was 14 f 22%. In the six patients with 
abnormal auscultation, the mean perception was 
33 f 33% (range O-89%), a value similar to that 
observed for MCT+ patients. Two patients were 
asymptomatic throughout the test, and four 
complained of cough, chest discomfort and 
dyspnoea. 
SENSITIVITY AND SPECIFICITY OF ABNORMAL 
LUNG SOUNDS AND SYMPTOMS 
Wheeze detection with or without reduced BSI 
was 44% sensitive and 92.5% specific to detect a 
20% fall in FEV,. For decreased BSI alone, the 
figures were 41 and 8 l%, respectively. Coupling 
wheeze detection to decreased BSI raises the 
sensitivity to 85%, but decreases specificity to 
77%. Sensitivity of wheezes alone was 7.4% and 
specificity was 92*5%. 
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The presence of symptoms (taken as a binary 
variable) was 92% sensitive but only 50% specific 
to detect a 20% fall in FEV,. This low specificity 
implies a high false-negative rate, which pre- 
cludes using the perception of symptoms to 
detect a fall in FEV, by 20% or more. 
Discussion 
In asthmatics, AH is characterized by an exag- 
gerated response of the airway to stimuli that 
would produce little or no effect in healthy 
individuals (8). The rapid alterations in airway 
smooth tone, which constitute the hallmark of 
AH in asthma, are regulated mainly, though not 
exclusively, by the autonomic neural pathways, 
especially the parasympathetic pathway (89). 
Schematically, when a substance such as metha- 
choline is inhaled, it can produce bronchospasm 
by direct stimulation of airway smooth muscle 
and/or the activation of fibre receptors in the 
bronchial mucosa (8-10) as well as changes in 
airway secretions and ventilatory control (9). 
Considering the relationship between lung 
sounds and airflow observed in healthy individ- 
uals (11) and in patients with obstructive lung 
disease (12), it is reasonable to expect that if 
bronchospasm is severe enough to produce a 
significant fall in FEV,, it must also affect lung 
sounds noticeably. 
Two pulmonary sounds are potentially use- 
ful to assess bronchosconstriction; wheezes 
and inspiratory breath (vesicular) sound. The 
reasons for monitoring wheezes are well known 
(13), and will not be dealt with here. In contrast, 
the rationale for monitoring BSI is less obvious 
and will be considered briefly. It is based upon 
the following arguments. First, since Lalnnec 
(14) first observed faint breath sounds in patients 
with emphysema, the association between this 
sign and significant airilow limitation has been 
clearly demonstrated in patients with chronic 
obstructive lung disease (15-19). Second, it is a 
common observation that in asthmatics with 
severe bronchospasm wheezes can be absent and 
breath (Vesicular) sound may be so faint that the 
chest is sometimes described as silent (20). 
Finally, there is experimental evidence that 
inspiratory breath sound intensity may decrease 
noticeably at PD,, in non-wheezers whose 
challenge test was positive by spirometry (21). 
On examination of the present results, four 
patterns of acoustic changes were noticed. First, 
in roughly half of the MCT+ patients (n= 12), 
wheezes appeared at PD,,, either alone or in 
association with a decreased BSE. These findings 
are similar to those reported by several teams, 
both in children (2,3,22) and in adults (4). 
Swond, in the majority of MCT+ patients 
(n=20), abnormal lung sounds (either wheeze, 
decreased BSI or both) were noticed one to 
several steps before PD,,. This pattern has also 
been documented by investigators dealing with 
wheeze detection (24,22) but, in these studies, 
changes in BSI were not assessed. Third, in four 
MCT+ patients, auscultation was entirely nor- 
mal; similar false-negative cases were previously 
documented both in children (2,3) and adults 
(4,23). Finally, abnormal lung sounds were 
observed in six MAC - patients; wheezes in 
two, and diminished BSI in the remaining four. 
Regarding the question addressed in this 
study, two answers are possible according to the 
interpretation of the relationship between abnor- 
mal lung sounds and AH. If AH is considered as 
a phenomenon likely to be described exclusively 
in terms of a 20% drop in FEV,, then it may be 
said that lung auscultation adds nothing to the 
current procedure of airway challenge testing. 
By contrast, if (pharmacologically-induced) 
bronehoconstriction is considered as an expres- 
sion of AH that may manifest itself, not only by 
a drop in FEV,, but also by changes in lung 
sounds, then the appearance of wheeze (and, by 
extension, that of an acute decrease in inspira- 
tory BSI) following the inhalation of a choliner- 
gic agent should be considered a legitimate 
criterion of test positivity as a fall in FEV,. Such 
an approach is similar to that adopted in real 
situations, e.g. an asthma attack triggered by 
exposure to a known stimulus; in this circum- 
stance, the development of wheeze is usually 
considered as a clinical expression of AH regard- 
less of the concomitant fall in FEV, (24-26). 
The application of the above concept would 
have had the following practical consequences 
for the study patients; first, smaller cumulative 
doses of methacholine would have been admin- 
istered to those who developed abnormal lung 
sounds before a 20% fall in FEV, without chang- 
ing the result of the test, and second, the test 
would have been considered as positive, instead 
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of negative, in those who developed abnor- 
mal lung sounds but whose FEV, fell by less 
than 20%. 
This study showed a good inter-observer 
agreement on the presence or absence of abnor- 
mal lung sounds detected by auscultation, a 
result that could be explained on several 
grounds. First, the examiners were relatively well 
experienced with lung auscultation - one is a 
board certified pulmonologist, whilst the other is 
a well-trained nurse, who has been responsible 
for lung auscultation in the authors’ laboratory 
for more than 10 yr. Second, the study observers 
went through a practice run before the study 
which must have contributed to minimize inter- 
observer disagreement due to poor communi- 
cation (18). Finally, the particular type of 
stethoscope used allowed the study observers to 
listen to the same sound simultaneously, thus 
virtually eliminating disagreement due to within- 
subject variability of lung sounds. 
It can be argued that this study is limited by 
the lack of objective sound and airflow measure- 
ments, but the authors do not think this to be so. 
Indeed, wheezes are easily detectable by auscul- 
tation, and this method correlates well with 
computerized means (4). On the other hand, in 
this study, BSI was assessed only in terms of 
change from a known (baseline) level which 
served as control, a much easier assessment han 
absolute level estimation (17,18). Finally, the 
study patients were constantly encouraged to 
make deep, fast inspirations and they apparently 
did so; therefore, the authors believe that 
changes in inspiratory airflow likely to have 
influenced breath sounds could have resulted 
only from airway narrowing due to broncho- 
constriction itself and not from fatigue or poor 
co-operation. 
In conclusion, like other recent studies 
(2,19,27,28), the present paper gives support to 
the idea that the stethoscope remains an invalu- 
able tool to collect clinically relevant data in a 
fast and non-invasive way. This does not mean, 
however, that auscultation can replace spirom- 
etry reliably in airway challenge testing. Indeed, 
in the authors’ view, the two methods should not 
be opposed to one another as they explore 
different aspects of airway obstruction; they are 
complementary and should be carried out con- 
currently. In this context, auscultation may 
prove useful to shorten the challenge and 
increase its safety until objective acoustic indices 
are described which are capable of reflecting 
airway obstruction more precisely. 
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